Growth of peripheral and central nervous system tumors is supported by cytoplasmic c-FOS in humans and mice

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Silvestrea, David C ^a,b   Gilb, Germán A ^a,c   Tomasinic, Nicolás ^a,d   Bussolinod, Daniela F ^a   Caputto, Beatriz L ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Universite Paris Sud   (France)

^c Scripps Institute   (United States)

^d UNIVERSIDAD NACIONAL DE SALTA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN C FOS;

ANIMAL MODEL; ARTICLE; BIOGENESIS; BRAIN TUMOR; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; GLIOBLASTOMA; HUMAN; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PROTEIN EXPRESSION; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS; BRAIN; C57BL MOUSE; CENTRAL NERVOUS SYSTEM TUMOR; DISEASE MODEL; GENOTYPE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHOSPHORYLATION;

ANIMALIA; MUS;

ANIMALS; BRAIN; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM NEOPLASMS; CYTOPLASM; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM; GENOTYPE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROFIBROMATOSIS 1; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 77949764066     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009544     Document Type: Article

References (37)

1. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072: 129-157.
2. Morgan J, Curran T (1995) Immediate early genes: ten years on. Trends Neurosci 18: 66-67.
3. Caputto BL, Guido ME (2000) Immediate early gene expression within the visual system: light and circadian regulation in the retina and the suprachiasmatic nucleus. Neurochem Res 25: 153-162.
4. Kouzarides T, Ziff E (1989) Leucine zippers of Fos, Jun and GCN4 dictate dimerization specificity and thereby control DNA binding. Nature 340: 568-571.
5. Guido ME, de Arriba GA, Bussolino DF, Caputto BL (1996) The Immediate Early Gene c-fos regulates the synthesis of phospholipids but not of gangliosides. J Neurosci Res 43: 93-98.
6. Bussolino DF, de Arriba Zerpa GA, Grabois VR, Conde CB, Guido ME, et al. (1998) Light affects c-Fos expression and phospholipid biosynthesis in both retinal ganglion cells and photoreceptor cells. Molec Brain Res 58: 10-15.
7. Bussolino DF, Guido ME, Gil GA, Borioli GA, Renner ML, et al. (2001) c-Fos associates with the endoplasmic reticulum and activates phospholipid metabolism. FASEB J 15: 556-558.
8. Gil GA, Bussolino DF, Portal MM, Pecchio AA, Renner ML, et al. (2004) c-Fos activated phospholipid synthesis is required for neurite elongation in differentiating PC12 cells. Mol Biol Cell 15: 1881-1894.
9. Crespo PM, Silvestre DC, Gil GA, Maccioni HJF, Daniotti JL, et al. (2008) c-Fos activates glucosylceramide synthase and glycolipid synthesis in PC12 cells. J Biol Chem 283: 31163-31171.
10. Portal MM, Ferrero GO, Caputto BL (2007) N-terminal c-Fos tyrosine phosphorylation regulates c-Fos/ER association and c-Fos-dependent phospholipid synthesis activation. Oncogene 26: 3551-3558.
11. Silvestre DC, Maccioni HJ, Caputto BL (2009) Content of endoplasmic reticulum and Golgi complex membranes positively correlates with the proliferative status of brain cells. J Neurosci Res 87: 857-865.
12. Moenner M, Pluquet O, Bouchecareilh M, Chevet E (2007) Integrated endoplasmic reticulum stress responses in cancer. Cancer Res 67: 10631-10634.
13. Guha A, Lau N, Huvar I, Gutmann D, Provias J, et al. (1996) Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene 12: 507-513.
14. Serra E, Puig S, Otero D, Gaona A, Kruyer H, et al. (1997) Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet 61: 512-519.
15. Cichowski K, Jacks T (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104: 593-604.
16. Ferner RE, Gutmann DH (2002) International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 62: 1573-1577.
17. Rasmussen SA, Yang Q, Friedman JM (2001) Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 68: 1110-1118.
18. Reilly KM, Loisel DA, Bronson RT, McLaughlin ME, Jacks T (2000) Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat Genet 26: 109-113.
19. Cichowski K, Shih TS, Schmitt E, Santiago S, Reilly K, et al. (1999) Mouse models of tumor development in neurofibromatosis type 1. Science 286: 2172-2176.
20. Costa RM, Silva AJ (2003) Mouse models of neurofibromatosis type I: bridging the GAP. Trends Mol Med 9: 19-23.
21. Zhu Y, Parada LF (2002) The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2: 616-626.
22. Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF (2002) Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296: 920-922.
23. Smeyne RJ, Schilling K, Robertson L, Luk D, Oberdick J, et al. (1992) fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system. Neuron 8: 13-23.
24. Penner MR, McFadyen MP, Pinaud R, Carrey N, Robertson HA, et al. (2002) Age-related distribution of c-fos expression in the striatum of CD-1 mice after acute methylphenidate administration. Brain Res Dev Brain Res 135: 71-77.
25. Johnson RS, Spiegelman BM, Papaioannou V (1992) Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71: 577-586.
26. Wang ZQ, Ovitt C, Grigoriadis AE, Möhle-Steinlein U, Rü ther U, et al. (1992) Bone and haematopoietic defects in mice lacking c-fos. Nature 360: 741-745.
27. Fleischmann, A. Hafezi F, Elliott C, Reme CE, Ruther U, et al. (2000) Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev 14: 2695-2700.
28. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70.
29. de Arriba Zerpa GA, Guido ME, Bussolino DF, PasquaréS, Castagnet P, et al. (1999) Light stimulation activates retina ganglion cell lysophosphatidic acid acyl transferase and phosphatidic acid phosphatase by a Fos-dependent mechanism. J Neurochem 73: 1228-35.
30. Borioli GA, Caputto BL, Maggio B (2001) c-Fos is surface active and interacts differentially with phospholipid monolayers. Biochem Biophys Res Commun 280: 9-13.
31. Cammer W, Tansey FA, Brosnan CF (1989) Gliosis in the spinal cords of rats with allergic encephalomyelitis: immunostaining of carbonic anhydrase and vimentin in reactive astrocytes. Glia 2: 223-230.
32. Leppa S, Eriksson M, Saffrich R, Ansorge W, Bohmann D (2001) Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells. Mol Cell Biol 21: 4369-4378.
33. Chipuk JE, Maurer U, Green DR, Schuler M (2003) Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 4: 371-381.
34. Green RD, Kroemer G (2009) Cytoplasmic functions of the tumour suppressor p53. Nature 458: 1127-1130.
35. Guido ME, Caputto BL (1990) Labeling of retina and optic tectum phospholipids in chickens exposed to light or dark. J Neurochem 55: 1855-1860.
36. Wang Z, Kang JS, Li Y, Yuan ZX, Liu SS, et al. (2006) The effects of dexamethasone on rat brain cortical nuclear factor kappa B (NF-kappaB) in endotoxic shock. Toxicol Appl Pharmacol 214: 263-269.
37. Scerbo MJ, Rupil LL, Bibolini MJ, Roth GA, Monferran CG (2009) Protective effect of a synapsin peptide genetically fused to the B subunit of Escherichia coli heat-labile enterotoxin in rat autoimmune encephalomyelitis. J Neurosci Res 87: 2273-2281.